Thomas E. Wagner

9.7k total citations · 2 hit papers
198 papers, 7.9k citations indexed

About

Thomas E. Wagner is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Thomas E. Wagner has authored 198 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Molecular Biology, 74 papers in Genetics and 37 papers in Immunology. Recurrent topics in Thomas E. Wagner's work include Animal Genetics and Reproduction (53 papers), Virus-based gene therapy research (29 papers) and Immunotherapy and Immune Responses (26 papers). Thomas E. Wagner is often cited by papers focused on Animal Genetics and Reproduction (53 papers), Virus-based gene therapy research (29 papers) and Immunotherapy and Immune Responses (26 papers). Thomas E. Wagner collaborates with scholars based in United States, Germany and Japan. Thomas E. Wagner's co-authors include Stephen F. Vatner, Xianzhong Yu, John J. Kopchick, Eric Holle, Junichi Sadoshima, David C. Wight, Andrzej Bartke, Peiyong Zhai, Shumin Gao and Bin Tian and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Thomas E. Wagner

192 papers receiving 7.6k citations

Hit Papers

Sirt1 Regulates Aging and Resistance to Oxidative Stress ... 1997 2026 2006 2016 2007 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Wagner United States 42 4.4k 1.6k 1.6k 1.2k 1.1k 198 7.9k
Grant A. Mitchell Canada 56 5.8k 1.3× 886 0.5× 1.1k 0.7× 784 0.6× 3.7k 3.3× 206 11.8k
Ali Pedram United States 48 3.8k 0.9× 1.6k 1.0× 4.0k 2.5× 1.0k 0.8× 1.0k 0.9× 78 9.2k
Stephan Herzig Germany 46 4.2k 1.0× 1.2k 0.7× 645 0.4× 511 0.4× 3.3k 3.0× 149 9.0k
Mark H. Rider Belgium 51 5.6k 1.3× 788 0.5× 352 0.2× 524 0.4× 1.3k 1.1× 138 7.7k
Gary L. Firestone United States 57 7.4k 1.7× 1.7k 1.0× 2.3k 1.4× 236 0.2× 475 0.4× 156 11.2k
Hirotoshi Tanaka Japan 46 4.2k 1.0× 927 0.6× 1.0k 0.6× 346 0.3× 1.0k 0.9× 175 8.0k
Hiroyuki Motoshima Japan 35 6.5k 1.5× 822 0.5× 291 0.2× 617 0.5× 1.7k 1.6× 97 9.7k
Uwe Schlattner France 55 6.9k 1.6× 517 0.3× 334 0.2× 1.1k 0.9× 1.8k 1.6× 153 10.1k
Johannes V. Swinnen Belgium 61 8.2k 1.9× 1.2k 0.8× 1.5k 0.9× 282 0.2× 668 0.6× 188 13.4k
Didier Vertommen Belgium 52 5.4k 1.2× 533 0.3× 769 0.5× 266 0.2× 920 0.8× 193 7.8k

Countries citing papers authored by Thomas E. Wagner

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Wagner more than expected).

Fields of papers citing papers by Thomas E. Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Wagner. The network helps show where Thomas E. Wagner may publish in the future.

Co-authorship network of co-authors of Thomas E. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Wagner. A scholar is included among the top collaborators of Thomas E. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Wagner. Thomas E. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Zhihui, et al.. (2012). An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation. International Journal of Oncology. 41(2). 661–669. 4 indexed citations
2.
Li, Jinhua, et al.. (2008). Whole tumor cell vaccine with irradiated S180 cells as adjuvant. Vaccine. 27(4). 558–564. 15 indexed citations
3.
Zhai, Peiyong, Shumin Gao, Eric Holle, et al.. (2007). Glycogen Synthase Kinase-3α Reduces Cardiac Growth and Pressure Overload-induced Cardiac Hypertrophy by Inhibition of Extracellular Signal-regulated Kinases. Journal of Biological Chemistry. 282(45). 33181–33191. 55 indexed citations
4.
Zhai, Peiyong, Jonathan Galeotti, Eric Holle, et al.. (2006). An Angiotensin II Type 1 Receptor Mutant Lacking Epidermal Growth Factor Receptor Transactivation Does Not Induce Angiotensin II–Mediated Cardiac Hypertrophy. Circulation Research. 99(5). 528–536. 79 indexed citations
5.
Langheinrich, Ulrike, Gabriele Vacun, & Thomas E. Wagner. (2003). Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia☆. Toxicology and Applied Pharmacology. 193(3). 370–382. 202 indexed citations
6.
Wagner, Thomas E., et al.. (2002). Pentopyranosyl Oligonucleotide Systems. Helvetica Chimica Acta. 84. 5 indexed citations
7.
Xie, Yuran, et al.. (2001). Cytoplasmic Expression of Ribozyme In Zebrafish Using a T7 Autogene System. Current Issues in Molecular Biology. 3(1). 1–6. 3 indexed citations
8.
Kornberg, A., et al.. (2001). Long‐term Combination of Interferon Alfa‐2b and Ribavirin for Hepatitis C Recurrence in Liver Transplant Patients. American Journal of Transplantation. 1(4). 350–355. 29 indexed citations
9.
Vatner, Dorothy E., Kuniya Asai, Mitsunori Iwase, et al.. (1998). Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.. Journal of Clinical Investigation. 101(9). 1916–1922. 41 indexed citations
10.
Gaudin, Christophe, Yoshihiro Ishikawa, David C. Wight, et al.. (1995). Overexpression of Gs alpha protein in the hearts of transgenic mice.. Journal of Clinical Investigation. 95(4). 1676–1683. 116 indexed citations
11.
Tang, Kechun, et al.. (1994). Testosterone Feedback on Gonadotropin Secretion and Gene Expression in Transgenic Mice Expressing Human Growth Hormone Gene. Journal of Andrology. 15(1). 9–14. 5 indexed citations
13.
Steger, Richard W., Andrzej Bartke, T. A. Parkening, et al.. (1991). Effects of Heterologous Growth Hormones on Hypothalamic and Pituitary Function in Transgenic Mice. Neuroendocrinology. 53(4). 365–372. 40 indexed citations
14.
Ghosh, Pradip, Luciano Debéljuk, Thomas E. Wagner, & Andrzej Bartke. (1991). Effect of Immunoneutralization of Neuropeptide Y on Gonadotropin and Prolactin Secretion in Normal Mice and in Transgenic Mice Bearing Bovine Growth Hormone Gene*. Endocrinology. 129(2). 597–602. 16 indexed citations
15.
McGrane, M.M., et al.. (1990). Production of transgenic pigs harbouring a rat phosphoenolpyruvate carboxykinase-bovine growth hormone fusion gene.. PubMed. 41. 89–96. 29 indexed citations
16.
Reed, Michael A., et al.. (1990). A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocysts. Theriogenology. 33(4). 901–913. 79 indexed citations
17.
Hanson, Richard W., Maria Hatzoglou, Mary M. McGrane, et al.. (1989). Molecular Biology and Nutrition Research. Journal of Nutrition. 119(7). 957–964. 3 indexed citations
18.
Wagner, Thomas E., Finnie A. Murray, Brijinder S. Minhas, & D.C. Kraemer. (1984). The possibility of transgenic livestock. Theriogenology. 21(1). 29–44. 15 indexed citations
19.
Wagner, Thomas E., et al.. (1983). Quality Circles: An Alternative for Higher Education.. 34(1). 11–14. 1 indexed citations
20.
Wagner, Thomas E.. (1974). A Development Program for Middle Managers..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026